Oxurion NV Partners with Prevent Blindness to Educate Public on Diabetes-related Eye Disease
Both Oxurion and Prevent Blindness join forces during November to educate the public on risk factors, symptoms, treatment options, and financial assistance resources.
Research opportunities for treating age-related macular degeneration
Age-related macular degeneration (or AMD) is the leading cause of blindness. At Oxurion, we’re discovering new ways to treat both forms.
3 reasons why we need to raise diabetic eye disease awareness
Diabetic eye diseases affect millions of people globally, and still there's a high unmet need in diagnosis and treatment. It's high time to get the message across to risk groups.
9 striking facts about diabetic eye disease
In this post, we’ll share some striking facts and numbers about diabetes and diabetic eye disease.
Sehnaz Karadeniz on tackling diabetes and related vision problems
Diabetic eye disease is currently one of the leading causes of preventable blindness in the working population worldwide. Early treatment and diagnosis is crucial for prevention.
Creating Diabetic Eye Disease Awareness with Prevent Blindness
This November, in support of Diabetic Eye Disease Awareness Month, Oxurion is partnering with Prevent Blindness and its sight saving efforts.
“We need therapies fighting different hallmarks simultaneously”
PDR and DME are two manifestations of diabetic retinopathy (DR), and in many respects they stem from the same cause, explains Prof. Alan Stitt, Dean of Innovation & Impact and ...
“JETREA has a group of very loyal users worldwide”
Vinciane Vangeersdaele joined the Oxurion leadership team this past year. With extensive experience in commercializing pharmaceutical portfolios worldwide, including in ...